The whole world of commodities in one App!

Watch Management & Expert Interviews, Site-Visit-Videos, News Shows and receive top and up to date Mining Information on your mobile device worldwide!

Download our unique App for free!
Commodity-TV Play Store
Commodity-TV App Store

Social Media

Cannabis stocks could face a new boom

Medical cannabis is used more and more all over the world. In Canada, it can soon be bought by anyone legally and without conditions.

There are special cannabis clinics in Canada and the plant has been used there for medicinal purposes for some time. The fact that the acquisition of cannabis will now be legalised in Canada from 18 October on, is already a sensation. Purchase, cultivation and possession are then permitted. In 2013, Uruguay began lifting the ban by allowing cannabis use under state control.

But Canada isn't just any small country. According to Health Canada's data, the market for medical devices is growing strongly, so there is also great potential in the neighboring USA. An average annual growth rate of 29 percent is expected between 2014 and 2020. Mind you, only for medical purposes.

Canada's move towards legalisation could also encourage other countries to relax or lift the ban on cannabis. If investors are considering investing in the cannabis industry, they should nevertheless pay attention to the quality of the companies. After all, many companies have sprung up that have hardly any market opportunities and thus also no stock market opportunities.

The Canadian Cannabis Conference in Frankfurt on 21 and 22 October will provide an opportunity to find out more. This is the first of its kind and German investors and Canadian cannabis companies meet.

Canada's largest producer of organic cannabis is the Green Organic Dutchman Holdings. The cultivation facilities are located in Ontario, Quebec and Jamaica or are being built or expanded there. For medical purposes, the company may also deliver to Germany. The acquisition of HemPoland will allow Green Organic Dutchman to generate immediate revenues.

Another interesting company in the industry is Ravenquest BioMed, a licensed cannabis producer with sites in Ontario and Alberta. Ravenquest BioMed maintains a research partnership with McGill University in Montreal. The annual production target is 7,000 kilograms of cannabis.

In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the English version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies:

Newsletter / Archiv